Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (401-410 of 592) with videos related to

Pageof 60
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2021
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older AdultsBharati Kochar, Virginia Pate, Michael D Kappelman, et al.
Gastroenterology|November 21, 2024
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative ColitisSiddharth Singh, Edward V Loftus, Berkeley N Limketkai, et al.
Gut|May 24, 2012
Oral contraceptives, reproductive factors and risk of inflammatory bowel diseaseHamed Khalili, Leslie M Higuchi, Ashwin N Ananthakrishnan, et al.
The Australian and New Zealand Journal of Surgery|November 1, 1989
Jejunogastric intussusception: therapeutic optionsB K Jain, U Lodh, S S Chandra, et al.
Inflammatory Bowel Diseases|January 8, 2015
Measures of obesity and risk of Crohn's disease and ulcerative colitisHamed Khalili, Ashwin N Ananthakrishnan, Gauree G Konijeti, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2016
Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infectionZ Kassam, C Cribb Fabersunne, M B Smith, et al.
Cell Host & Microbe|May 12, 2017
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel DiseasesAshwin N Ananthakrishnan, Chengwei Luo, Vijay Yajnik, et al.
Annals of Internal Medicine|March 7, 2012
Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort studyAshwin N Ananthakrishnan, Leslie M Higuchi, Edward S Huang, et al.
Journal of Clinical Gastroenterology|August 2, 2007
Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel diseaseAshwin N Ananthakrishnan, Tan Attila, Mary F Otterson, et al.
BMC Gastroenterology|January 7, 2019
Cancer risk in microscopic colitis: a retrospective cohort studyAlexander Levy, Nienke Z Borren, Benjamin Maxner, et al.
Pageof 60

Showing results (401-410 of 592) with videos related to

Sort By:
Pageof 60
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2021
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older AdultsBharati Kochar, Virginia Pate, Michael D Kappelman, et al.
Gastroenterology|November 21, 2024
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative ColitisSiddharth Singh, Edward V Loftus, Berkeley N Limketkai, et al.
Gut|May 24, 2012
Oral contraceptives, reproductive factors and risk of inflammatory bowel diseaseHamed Khalili, Leslie M Higuchi, Ashwin N Ananthakrishnan, et al.
The Australian and New Zealand Journal of Surgery|November 1, 1989
Jejunogastric intussusception: therapeutic optionsB K Jain, U Lodh, S S Chandra, et al.
Inflammatory Bowel Diseases|January 8, 2015
Measures of obesity and risk of Crohn's disease and ulcerative colitisHamed Khalili, Ashwin N Ananthakrishnan, Gauree G Konijeti, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2016
Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infectionZ Kassam, C Cribb Fabersunne, M B Smith, et al.
Cell Host & Microbe|May 12, 2017
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel DiseasesAshwin N Ananthakrishnan, Chengwei Luo, Vijay Yajnik, et al.
Annals of Internal Medicine|March 7, 2012
Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort studyAshwin N Ananthakrishnan, Leslie M Higuchi, Edward S Huang, et al.
Journal of Clinical Gastroenterology|August 2, 2007
Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel diseaseAshwin N Ananthakrishnan, Tan Attila, Mary F Otterson, et al.
BMC Gastroenterology|January 7, 2019
Cancer risk in microscopic colitis: a retrospective cohort studyAlexander Levy, Nienke Z Borren, Benjamin Maxner, et al.
Pageof 60